Professor Steve Wicks Faculty of Engineering & Science

Professor Stephen Wicks is an Emeritus Professor of Pharmaceutical Science in the Faculty of Engineering and Science and an industrial pharmacist with interests in the application of scientific principles to the design and production of medicines for humans and animals. 

He completed a PhD at the University of Bath investigating the mathematics of the diffusion of drugs in polymer and active carbon composites to quantify the performance of 'artificial liver' devices. After post-doctoral teaching appointments at the University of Bath and Liverpool John Moores University, Professor Wicks joined GlaxoSmithKline and then Abbott Laboratories as a formulation scientist. Moving to Pfizer in 1986, Professor Wicks' interests broadened and at the end of his career with the company held positions as Vice President of Pharmaceutical Development Science and Technology with Pfizer Inc., with responsibility for over 800 scientists in the UK and the US, and Science Director on the board of Pfizer UK Group Ltd.

With Professors John Mitchell and Martin Snowden, Professor Wicks created the Medway Postdoctoral Scheme at the University of Greenwich, a training centre for early career pharmaceutical scientists with potential as industrial leaders. Professor Wicks' interest in academic pharmaceutical sciences broadened with the creation and directorship of other doctoral training partnerships, e.g. the Pfizer Institute of Materials Science at the University of Cambridge, and the Pfizer Analytical Research Centres at the Universities of Gent, Belgium and Tasmania, Australia.

Professor Wicks is Visiting Professor of Pharmaceutical Sciences at the University of Bath and is an Honorary Fellow of the University College London School of Pharmacy. His contribution to the development of pharmaceutical sciences in the UK has been recognised with the award of fellowships of the Royal Pharmaceutical Society and the Academy of Pharmaceutical Sciences of Great Britain. He is chair of the Royal Pharmaceutical Society Scientific Expert Advisory Panel and a member of the Advisory Board of the Academy of Pharmaceutical Sciences of Great Britain.